IL111404A - Pharmaceutical compositions for the enhancement ofmemory and cognition comprising 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles and some such novel compounds - Google Patents

Pharmaceutical compositions for the enhancement ofmemory and cognition comprising 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles and some such novel compounds

Info

Publication number
IL111404A
IL111404A IL11140494A IL11140494A IL111404A IL 111404 A IL111404 A IL 111404A IL 11140494 A IL11140494 A IL 11140494A IL 11140494 A IL11140494 A IL 11140494A IL 111404 A IL111404 A IL 111404A
Authority
IL
Israel
Prior art keywords
alkyl
triazoles
cognition
dialkyl
enhancement
Prior art date
Application number
IL11140494A
Other languages
English (en)
Other versions
IL111404A0 (en
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of IL111404A0 publication Critical patent/IL111404A0/xx
Publication of IL111404A publication Critical patent/IL111404A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL11140494A 1993-10-29 1994-10-26 Pharmaceutical compositions for the enhancement ofmemory and cognition comprising 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles and some such novel compounds IL111404A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14637393A 1993-10-29 1993-10-29

Publications (2)

Publication Number Publication Date
IL111404A0 IL111404A0 (en) 1994-12-29
IL111404A true IL111404A (en) 2000-02-17

Family

ID=22517085

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11140494A IL111404A (en) 1993-10-29 1994-10-26 Pharmaceutical compositions for the enhancement ofmemory and cognition comprising 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles and some such novel compounds

Country Status (18)

Country Link
EP (1) EP0725776B1 (xx)
JP (1) JP3779990B2 (xx)
KR (1) KR100321885B1 (xx)
CN (1) CN1046273C (xx)
AT (1) ATE155462T1 (xx)
AU (1) AU679130B2 (xx)
CA (1) CA2175352C (xx)
DE (1) DE69404322T2 (xx)
DK (1) DK0725776T3 (xx)
ES (1) ES2106567T3 (xx)
FI (1) FI961793A0 (xx)
GR (1) GR3024747T3 (xx)
HU (1) HUT74693A (xx)
IL (1) IL111404A (xx)
NO (1) NO961719D0 (xx)
NZ (1) NZ275620A (xx)
WO (1) WO1995011887A1 (xx)
ZA (1) ZA948352B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012240329A1 (en) 2011-04-04 2013-10-10 The Procter & Gamble Company Personal care article
MX2014001896A (es) 2011-08-15 2014-05-27 Procter & Gamble Metodos para el cuidado personal.
WO2013025761A1 (en) 2011-08-15 2013-02-21 The Procter & Gamble Company Conformable personal care articles
MX354696B (es) 2013-06-27 2018-03-15 Procter & Gamble Articulos para el cuidado personal.
EP3653611A1 (en) * 2018-11-15 2020-05-20 Centre National De La Recherche Scientifique Inhibitors of metallo-beta-lactamases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE541700C (de) * 1928-04-08 1932-01-15 C H Boehringer Sohn Akt Ges Verfahren zur Darstellung von 1,2,4-Triazolen
AR243171A1 (es) * 1985-10-29 1993-07-30 Merrell Pharma Inc Procedimiento para preparar 5-aril-2,4-dialquil-3h-1,2,4-triazol-3-tionas.
US5100906A (en) * 1990-04-19 1992-03-31 Merrell Dow Pharmaceuticals Inc. 5-aryl-4-alkyl-3h-1,2,4-triazole-3-thiones useful as memory enhancers
US5054050A (en) * 1990-04-30 1991-10-01 American Telephone & Telegraph Co. Drop testing in fiber to the home systems

Also Published As

Publication number Publication date
NO961719L (no) 1996-04-29
CA2175352A1 (en) 1995-05-04
ATE155462T1 (de) 1997-08-15
HUT74693A (en) 1997-01-28
GR3024747T3 (en) 1997-12-31
DE69404322D1 (de) 1997-08-21
DE69404322T2 (de) 1997-10-30
KR100321885B1 (ko) 2002-06-24
ES2106567T3 (es) 1997-11-01
NO961719D0 (no) 1996-04-29
CN1046273C (zh) 1999-11-10
WO1995011887A1 (en) 1995-05-04
CN1134147A (zh) 1996-10-23
FI961793A (fi) 1996-04-26
KR960705791A (ko) 1996-11-08
NZ275620A (en) 1999-01-28
AU679130B2 (en) 1997-06-19
IL111404A0 (en) 1994-12-29
JP3779990B2 (ja) 2006-05-31
DK0725776T3 (da) 1997-09-01
ZA948352B (en) 1995-06-26
AU7965494A (en) 1995-05-22
HU9601114D0 (en) 1996-07-29
FI961793A0 (fi) 1996-04-26
JPH09504290A (ja) 1997-04-28
CA2175352C (en) 1999-03-02
EP0725776B1 (en) 1997-07-16
EP0725776A1 (en) 1996-08-14

Similar Documents

Publication Publication Date Title
IL124537A0 (en) Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same
MX9701538A (es) Sales de un derivado del indol contra la migraña.
NZ221543A (en) 4-aminoquinoline derivatives and pharmaceutical compositions containing such
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
HU9201887D0 (en) Process for the production of //aralkyl-piperidine-4-yl/-methyl/-2a,3,4,5-tetrahydro-1-/2h/-acenaphtylene-1-on derivatives and of medical preparations containing them as active agents
IL111404A (en) Pharmaceutical compositions for the enhancement ofmemory and cognition comprising 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles and some such novel compounds
MY137475A (en) Chemical compounds.
PT823909E (pt) Nova quimica heterociclica
TW252979B (xx)
HU895830D0 (en) Process for the preparation of 1,2,3,4-tetrahydro-1,9-acridine-diamines and pharmaceutical compositions containing said compounds
BG106152A (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
DK0675895T3 (da) Etoposidderivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel og anvendelse deraf til fremstilling af et lægemiddel til anticancerbehandling
ZA858030B (en) Thiadiazole derivatives active on the central nervous system,process for their preparation and pharmaceutical compositions in which they are present
SE9203824D0 (sv) Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same
AP2001002154A0 (en) Hygromycin a derivatives (changed by the ISA to read hygromycin a derivatives as antibacterial agents.
HUT75343A (en) Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing the said compds.
EP0700395A1 (en) INDOLA DERIVATIVES AS INHIBITORS OF STEROIDAL 5-g (a) -REDUCTASE
ES2103237A1 (es) Nuevo compuesto derivado del cromeno
FI933652A0 (fi) Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler
WO1999005106A8 (fr) Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void